Crossmark

Aberrant p53 Immunostaining in Barrett’s Esophagus Predicts Neoplastic Progression: Systematic Review and Meta-Analyses

Crossref DOI link: https://doi.org/10.1007/s10620-019-05586-7

Published Online: 2019-03-26

Published Print: 2019-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Snyder, Patrick

Dunbar, Kerry

Cipher, Daisha J.

Souza, Rhonda F.

Spechler, Stuart Jon

Konda, Vani J. A.
License Information

Text and Data Mining valid from 2019-03-26
More Information

Article History

Received: 14 November 2018

Accepted: 8 March 2019

First Online: 26 March 2019

Compliance with ethical standards

:

: Rhonda F. Souza has served as a consultant and receives research support from Ironwood Pharmaceuticals. Stuart Jon Spechler has served as a consultant for Ironwood Pharmaceuticals. Vani J.A. Konda has received grant support from Pentax Medical and Ironwood Pharmaceuticals. Patrick Snyder, Kerry Dunbar, and Daisha J. Cipher have no conflict of interest.